Anti -?1-Adrenergic Receptor-Autoantibodies (Aptamer 110) (ID# 274)
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
DNA ?1-Adrenoceptor Autoantibodies(AABs) Protein n/a nM (reported value)Buffer 1: Tris buffer pH 7.3, 0.1% Tween-20, DMEM, 0.1% Tween-20
Buffer 2: Phosphate buffer pH 7.5, 0.1% Tween-20N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.Low affinity aptamers were removed from the column using both buffers.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Haberland, A., et al. "Aptamer Neutralization of Beta1-Adrenoceptor Autoantibodies Isolated From Patients With Cardiomyopathies." Circulation Research, 109 (2011): 986-992.
Have your aptamer oligo synthesized by one of our AFFILIATES
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
DNA
?1-Adrenoceptor Autoantibodies(AABs)
Protein
n/a nM (reported value)
Buffer 1: Tris buffer pH 7.3, 0.1% Tween-20, DMEM, 0.1% Tween-20
Buffer 2: Phosphate buffer pH 7.5, 0.1% Tween-20
N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Low affinity aptamers were removed from the column using both buffers.
